Fresenius Medical Care , the world’s top dialysis company, unveiled a $3.5-billion buy of Renal Care Group Inc on Wednesday, helping it overtake DaVita in the key U.S. market.
FMC will pay $48 per share in cash for shares of Nashville, Tennessee-based Renal Care, a deal that it said would be neutral to slightly accretive to earnings in 2006 and clearly accretive in 2007 and beyond.